Protease production by Burkholderia pseudomallei and virulence in mice

Acta Tropica

Volumn 74, Issue 2-3, 2000, Pages 215-220

  Gauthier, Y P ^a   Thibault, F M ^a   Paucod, J C ^a   Vidal, D R ^a  

^a CENTRE DE RECHERCHES   (France)

Author keywords

Burkholderia pseudomallei; Mice; Protease; Virulence

Indexed keywords

BACTERIAL ENZYME; PROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BACTERIAL VIRULENCE; BURKHOLDERIA CEPACIA; BURKHOLDERIA PSEUDOMALLEI; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; LETHALITY; MELIOIDOSIS; MOUSE; NONHUMAN; PROTEIN DEGRADATION; STRAIN DIFFERENCE;

ANIMALS; BURKHOLDERIA PSEUDOMALLEI; ENDOPEPTIDASES; FEMALE; INJECTIONS, INTRAPERITONEAL; LETHAL DOSE 50; MICE; VIRULENCE;

EID: 0033980498     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(99)00073-X     Document Type: Conference Paper

References (28)

1. Anuntagool N., Intachote P., Wuthiekanun V., White N.J., Sirisinha S. Lipopolysaccharide from nonvirulent Ara+ Burkholderia pseudomallei isolates is immunologically indistinguishable from lipopolysaccharide from virulent Ara- clinical isolates. Clin. Diagn. Lab. Immunol. 5(2):1998;225-229.
2. Ashdown L.R., Koehler J.M. Production of hemolysin and other extracellular enzymes by clinical isolates of Pseudomonas pseudomallei. J. Clin. Microbiol. 28(10):1990;2331-2334.
3. Booth B.A., Boesman-Finkelstein M., Finkelstein R.A. Vibrio cholera soluble hemagglutinin/protease is a metalloenzyme. Infect. Immun. 42:1983;639-644.
4. Brett P.J., DeShazer D., Woods D.E. Characterization of Burkholderia pseudomallei and Burkholderia pseudomallei-like strains. Epidemiol. Infect. 118:1997;137-148.
5. Chambon L. Analyse serologique de l'antigene somatique de Malleomyces pseudomallei. Ann. Inst. Pasteur. 98:1960;405-415.
6. Colling M., Nigg C., Heckly R.J. Toxins of Pseudomonas pseudomallei I. Production in vitro. J. Bacteriol. 76:1958;422-426.
7. Dannenberg A.M., Scott E.M. Melioidosis: pathogenesis and immunity in mice and hamster. I. Studies with virulent strains of Malleomyces pseudomallei. J. Exp. Med. 107:1958;153-166.
8. Dannenberg A.M., Scott E.M. Melioidosis: pathogenesis and immunity in mice and hamster. II. Studies with avirulent strains of Malleomyces pseudomallei. J. Exp. Med. 34:1958;1099-1121.
9. Galimand, M., 1986. Le bacille de Whitmore: caracterisation de Pseudomonas pseudomallei, et physiopathologie de la mélioïdose. Thesis of University, Paris VII.
10. Gray L., Kreger A. Microscopic examination of rabbit lung damage produced by Pseudomonas aeruginosa proteases. Infect. Immun. 23:1979;150-159.
11. Haase A., Janzen J., Barrett S., Currie B. Toxin production by Burkholderia pseudomallei strains and correlation with severity of melioidosis. J. Med. Microbiol. 46:1997;557-563.
12. Haussler S., Nimtz M., Domke T., Wray V., Steinmetz I. Purification and characterization of a cytotoxic exolipid of Burkholderia pseudomallei. Infect. Immun. 66(4):1998;1588-1593.
13. Heckly R.J. Differentiation of exotoxin and other biologically active substances in Pseudomonas pseudomallei filtrates. J. Bacteriol. 88:1964;1730-1736.
14. Ho M., Schollaardt T., Smith M.D., Perry M.B., Brett P.J., Chaowagul W., Bryan L.E. Specific and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies. Infect. Immun. 65(9):1997;3648-3653.
15. Ismail G., Mohamed R., Embi M.N. Pathogenesis of melioidosis: the enigma continues. Puthucheary S.D., Malik Y.A. Melioidosis. Prevailing Problems and Future Directions. Selected Papers from the First International Symposium on Melioidosis, Kuala Lumpur. 1994;55-66.
16. Jayanetra P., Vorachit M., Bhatarakamol S. Pseudomonas pseudomallei: II. Laboratory and experimental studies in animals. South East Asian J. Trop. Med. Pub. Health. 6(1):1975;10-17.
17. Leakey A.K., Ulett G.C., Hirst R.G. BALB/c and C57BL/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis. Microb. Pathog. 24(5):1998;269-275.
18. Martin P., Gallimand M., Dodin A. Etude in vivo d'un extrait antigenique de Pseudomonas pseudomallei. 1 - Effet paradoxal lors d'une infection d'epreuve precoce. Med. Mal. Inf. 10(1):1980;19-23.
19. Martin P., Gallimand M., Dodin A. Etude in vivo d'un extrait antigenique de Pseudomonas pseudomallei. 2 - Etude de l'immunite acquise apres infection par Pseudomonas pseudomallei et effet paradoxal induit par transfert de serums. Med. Mal. Inf. 10(3):1980;169-172.
20. Matsuura M., Kawahara K., Ezaki T., Nakano M. Biological activities of lipopolysaccharide of Burkholderia (Pseudomonas) pseudomallei. FEMS Microbiol. Lett. 137:1996;79-83.
21. McKevitt A.I., Bajaksouzian S., Klinger J.D., Woods D.E. Purification and characterization of an extracellular protease from Pseudomonas cepacia. Infect. Immun. 57(3):1989;771-778.
22. Miller W.R., Pannell L., Cravitz L., Tanner W.A., Rosebury T. Studies on certain biological characteristics of Malleomyces mallei and Malleomyces pseudomallei. II. Virulence and infectivity for animals. J. Bacteriol. 55:1948;127-135.
23. Mims C.A., Dimmock N.J., Nash A., Stephen J. Mechanisms of cell and tissue damage. Mims' Pathogenesis of Infectious Diseases. Fourth edition:1995;207-208 Academic Press, London.
24. 2+ for optimal exoprotease production in chemically defined media. Appl. Environ. Microbiol. 61(8):1995;3151-3153.
25. Reed L.J., Muench H. A simple method of estimating 50% endpoints. Am. J. Hyg. 27(3):1938;493-497.
26. Sexton M.M., Jones A.L., Chaowagul W., Woods D.E. Purification and characterization of a protease from Pseudomonas pseudomallei. Can. J. Microbiol. 40:1994;903-910.
27. Veljanov D., Vesselinova A., Nikolova S., Najdenski H., Kussovski V., Markova N. Experimental melioidosis in inbred mouse strains. Zbl. Bakt. 283:1996;351-359.
28. Yang H., Kool C.D., Sokol P. Ability of Burkholderia pseudomallei malleobactin to acquire transferrin-bound, lactoferrin-bound, and cell-derived iron. Infect. Immun. 61(2):1993;656-662.